ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,270Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 559

$617K Total Retail Price of All Prescriptions

Rank: 18 out of 559

294 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 294 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 5,547 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 389 250 1 2
HYDROCODONE-ACETAMINOPHEN 346 182 S3 2 7
LISINOPRIL 340 281 3 1
SIMVASTATIN 333 228 4 3
OMEPRAZOLE 295 174 5 4
HYDROCHLOROTHIAZIDE 217 122 6 8
METFORMIN HCL 199 152 7 5
METOPROLOL TARTRATE 193 106 8 12
RANITIDINE HCL 168 75 9 26
CARISOPRODOL 157 36 R 10 73
AMLODIPINE BESYLATE 133 88 11 6
PREDNISONE 121 84 12 49
AZITHROMYCIN 117 68 13 39
HYDROXYZINE HCL 112 27 R 14 108
GABAPENTIN 104 48 15 9
HYDRALAZINE HCL 99 61 16 143
OXYCODONE-ACETAMINOPHEN 95 46 S2 17 44
FLUTICASONE PROPIONATE 93 50 18 22
NAPROXEN 92 33 19 79
SPIRONOLACTONE 92 56 19 74
TRIAMCINOLONE ACETONIDE 91 51 21 84
ACETAMINOPHEN-CODEINE 86 27 S3 22 83
AMITRIPTYLINE HCL 83 37 R 23 58
CITALOPRAM HBR 81 58 24 21
CRESTOR 78 60 25 33
OXYCODONE HCL-ACETAMINOPHEN 78 24 S2 25 70
METHOCARBAMOL 76 18 R 27 144
FELODIPINE ER 76 60 27 72
PROMETHAZINE HCL 75 32 R 29 116
SYNTHROID 72 68 30 64
CLONIDINE HCL 70 35 31 68
DOXYCYCLINE HYCLATE 70 34 31 102
METOPROLOL SUCCINATE 70 55 31 16
GEMFIBROZIL 68 39 34 71
JANUVIA 67 43 35 50
BENAZEPRIL HCL 67 41 35 85
CIPROFLOXACIN HCL 64 53 37 60
GLIPIZIDE 63 29 38 31
ZOLPIDEM TARTRATE 62 48 39 17
SINGULAIR 61 35 40 130
FUROSEMIDE 59 51 41 11
MELOXICAM 58 50 42 42
DICLOFENAC SODIUM 58 38 42 81
AMOXICILLIN 58 30 42 106
IBUPROFEN 57 23 45 30
ATORVASTATIN CALCIUM 56 39 46 20
ACTOS 55 31 47 87
SPIRIVA 55 32 47 67
NIASPAN 53 39 49 158
TERAZOSIN HCL 52 41 50 82
NEXIUM 51 39 51 57
ALENDRONATE SODIUM 51 38 51 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.